ADORA2A and neoplasm: In a murine PDAC model, combining an anti-CD73 antibody with an A2AR inhibitor significantly slowed tumor growth and reduced metastatic burden, which correlated with reduced infiltration of M2 macrophages and Treg cells within the TME [106].